The webpage provides useful resources and information for health professionals considering prescribing or supplying 'unapproved' medicinal cannabis products in Australia.

Version history: The clinical guidance documents were developed in 2017 and provide a broad overview of the evidence available at that time to support medicinal cannabis use. In February 2020, the National Drug and Alcohol Research Centre reviewed the clinical evidence for the use of medicinal cannabis published in refereed medical journals since the clinical guidance documents were released. Additional relevant studies were included in the bibliographies for epilepsy and pain. In November 2024, the clinical guidance documents were updated to reflect current regulatory information.

Clinical evidence, guidelines and resources for health professionals
The Commonwealth Department of Health, together with the NSW, Victorian and Queensland State Governments commissioned a multi-centre team of clinicians, experimental pharmacologists and other scientists at the University of New South Wales, University of Queensland and University of Sydney to review the current clinical evidence for medicinal cannabis in a range of conditions.